Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

PURPOSE: Nelarabine is effective in inducing remission in patients with relapsed and refractory T-cell acute lymphoblastic leukemia (T-ALL) but has not been fully evaluated in those with newly diagnosed disease. PATIENTS AND METHODS: From 2007 to 2014, Children’s Oncology Group trial AALL0434 (Clini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Dunsmore, Kimberly P., Winter, Stuart S., Devidas, Meenakshi, Wood, Brent L., Esiashvili, Natia, Chen, Zhiguo, Eisenberg, Nancy, Briegel, Nikki, Hayashi, Robert J., Gastier-Foster, Julie M., Carroll, Andrew J., Heerema, Nyla A., Asselin, Barbara L., Rabin, Karen R., Zweidler-Mckay, Patrick A., Raetz, Elizabeth A., Loh, Mignon L., Schultz, Kirk R., Winick, Naomi J., Carroll, William L., Hunger, Stephen P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526719/
https://ncbi.nlm.nih.gov/pubmed/32813610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados